DILH
AGN

Dai-ichi Life Holdings’s Allergan Inc AGN Stock Holding History

Dai-ichi Life Holdings’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-55,795
Closed -$11.9M – 667
2014
Q4 		$11.9M Buy
55,795
+13,400
+32% +$2.66M 0.34% 61
2014
Q3 		$7.55M Buy
42,395
+7,236
+21% +$1.2M 0.23% 98
2014
Q2 		$5.95M Sell
35,159
-7,658
-18% -$1.19M 0.19% 123
2014
Q1 		$5.31M Sell
42,817
-4,118
-9% -$501K 0.17% 136
2013
Q4 		$5.21M Sell
46,935
-907
-2% -$86.6K 0.16% 143
2013
Q3 		$4.33M Sell
47,842
-1,584
-3% -$142K 0.15% 138
2013
Q2 		$4.16M Buy
+49,426
New +$5.13M 0.15% 149

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Dai-ichi Life Holdings's AGN Position: Q1 2015 in Review

Dai-ichi Life Holdings sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 55,795 shares — an estimated $11.9M sold.

Dai-ichi Life Holdings first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $11.9M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Dai-ichi Life Holdings reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 55,795 Allergan Inc shares in Q1 2015, an estimated $11.9M.
  • Dai-ichi Life Holdings first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Dai-ichi Life Holdings's Allergan Inc position peaked at $11.9M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Dai-ichi Life Holdings's 13F filing for Q1 2015, filed 5 May 2015.